Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Diabetes, Obesity & Metabolism|October 30, 2022
A multicentre, randomized, double-blind, parallel, active- and placebo-controlled Phase 3 clinical study of the glucokinase activator PB-201 in treatment-naive patients with type 2 diabetes mellitus: A study protocolYing Du, Leili Gao, Xinhua Xiao, et al.
Journal of Diabetes Investigation|February 6, 2020
Silent hemoglobin variant during capillary electrophoresis: A case reportYanping Yuan, Xianghai Zhou, Leili Gao, et al.
Bone|November 4, 2019
Denosumab or romosozumab therapy and risk of cardiovascular events in patients with primary osteoporosis: Systematic review and meta- analysisFang Lv, Xiaoling Cai, Wenjia Yang, et al.
Nutrients|March 26, 2022
The Association between Non-Alcoholic Fatty Liver Disease (NAFLD) and Advanced Fibrosis with Serological Vitamin B12 Markers: Results from the NHANES 1999-2004Li Li, Qi Huang, Linjian Yang, et al.
Journal of Diabetes and Its Complications|September 19, 2018
Interactive effect of serum uric acid and total bilirubin for micro-vascular disease of type 2 diabetes in ChinaYanfeng Ren, Leili Gao, Xiaohui Guo, et al.
Journal of Diabetes|July 8, 2017
Prevalence of and risk factors for diabetic ketosis in Chinese diabetic patients with random blood glucose levels >13.9 mmol/L: Results from the CHina study in prEvalence of diabetiC Ketosis (CHECK) studyLeili Gao, Yufeng Li, Dadong Fei, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|October 11, 2024
Denosumab for Management of Hypercalcemia in Primary HyperparathyroidismYihan Zhao, Fang Zhang, Simin Zhang, et al.
Nature Medicine|May 25, 2023
Tirzepatide versus insulin glargine as second-line or third-line therapy in type 2 diabetes in the Asia-Pacific region: the SURPASS-AP-Combo trialLeili Gao, Byung Wan Lee, Manoj Chawla, et al.
Case Reports in Immunology|March 11, 2026
False Elevation of Parathyroid Hormone in a Patient With Lung Metastasis of Rectal Cancer After Immunotherapy: A Case Report and Literature ReviewChang-Sheng Xia, Lingli Zhou, Chendi Jing, et al.
Cell Reports. Medicine|April 9, 2026
GZR18, a GLP-1 analog with once-weekly or bi-weekly dosing for body weight management: A randomized, placebo-controlled, phase 1b/2a trialLinong Ji, Leili Gao, Ruihua Dong, et al.
Pageof 4